Fabio Eisfeld: Plasma-derived Drugs Cannot Be Produced Synthetically, They Depend Entirely On The Generosity of Healthy Donors
Fabio Eisfeld, HR Manager Latam at Grifols, shared on LinkedIn:
”Last week, we celebrated International Plasma Awareness Week (IPAW2025 ), and Grifols employees in Latin America actively participated!
Here are photos of colleagues dressed in yellow to contribute to this important moment.
Created by the Plasma Protein Therapeutics Association (PPTA), IPAW is dedicated to highlighting the value of human plasma, recognizing the generosity of donors, and promoting understanding of plasma-derived therapies.
Plasma-derived drugs cannot be produced synthetically; they depend entirely on the generosity of healthy donors.
These donations provide essential proteins, which often represent the only therapy available to patients.
Millions of people around the world, both those suffering from rare and chronic diseases and those facing trauma or medical emergencies, rely on plasma-derived therapies.
We remain firm in our goal: to produce and deliver medicines that provide quality of life to our patients!”
-
Jun 9, 2026, 17:55Can We Prevent Postpartum Blood Clots without Putting Most Women on Heparin? – RPTH Journal
-
Jun 9, 2026, 17:54Lucky Oseghale Oloboh: Health Is Power, Health Is Personal, and Health Is Our First Responsibility in Life’s Journey on Mother Earth
-
Jun 9, 2026, 17:53Ajay Samkaria: How ABO Subgroups Directly Impact Transfusion Safety
-
Jun 9, 2026, 17:51Alejandro González Veliz: Most Reported Aspirin Allergies Are Not True Hypersensitivity
-
Jun 9, 2026, 17:50Mary Cushman: It’s Time to Apply to Be on an ISTH SSC
-
Jun 9, 2026, 15:56Wolfgang Miesbach: A New Genetic Perspective on the Worldwide Burden of von Willebrand Disease
-
Jun 9, 2026, 15:34Shanon Marie Corsino: Nationwide Insights into Cancer-Associated Thrombosis in Filipino Patients
-
Jun 9, 2026, 15:20Murtuza Ali: Types of Blood Transfusions – A Quick Clinical Guide
-
Jun 9, 2026, 15:18Mital Jhaveri: TRACK Trial Findings Highlight the Unique Challenges of Advanced CKD